Literature DB >> 30550113

Dry eye symptoms and associated risk factors among adults aged 50 or more years in Central Mexico.

Enrique O Graue-Hernández1, Juan Carlos Serna-Ojeda1, Carlos Estrada-Reyes1, Alejandro Navas1, Jesús Arrieta-Camacho2, Aida Jiménez-Corona3,4.   

Abstract

OBJECTIVE: To determine the prevalence of dry eye symptoms (DES) and associated risk factors among adults in Tlaxcala, Mexico.
MATERIALS AND METHODS: A cross-sectional population-based study that included 1 508 individuals aged ≥50 years who answered the Dry Eye Questionnaire (DEQ5), with a score ranging between 0 and 22; the following categories were defined: no DES (<6); mild-moderate DES (6 to 11) and severe DES (≥12).
RESULTS: The prevalence of DES was 41.1% (95%CI 38.6-43.6), and was higher in women (OR=2.26, 95%IC 1.70-3.00), in individuals with smoking index of <10 (OR=1.40, 95%CI 1.05-1.87) and ≥10 pack-years (OR=2.29, 95%CI 1.44-3.63), compared to never-smokers, subjects with history of ever consuming alcohol (OR=1.31, 95%CI 1.02-1.70), and those receiving antihypertensive treatment (OR=1.29, 95%CI 1.00-1.65).
CONCLUSIONS: Dry eye symptoms were highly prevalent in the study population and were associated with sex, smoking, alcohol consumption, and antihypertensive medications.

Entities:  

Keywords:  Dry Eye Questionnaire 5; dry eye symptoms; prevalence

Mesh:

Year:  2018        PMID: 30550113     DOI: 10.21149/9024

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  3 in total

1.  A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel.

Authors:  Alejandro Rodriguez-Garcia; Alejandro Babayan-Sosa; Arturo Ramirez-Miranda; Concepcion Santa Cruz-Valdes; Everardo Hernandez-Quintela; Julio C Hernandez-Camarena; Nallely Ramos-Betancourt; Regina Velasco-Ramos; Raul E Ruiz-Lozano
Journal:  Clin Ophthalmol       Date:  2022-04-28

2.  Identified risk factors for dry eye syndrome: A systematic review and meta-analysis.

Authors:  Lijun Qian; Wei Wei
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

3.  Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population.

Authors:  Homero Contreras-Salinas; Mariana Barajas-Hernández; Leopoldo Martín Baiza-Durán; Vanessa Orozco-Ceja; Lourdes Yolotzin Rodríguez-Herrera
Journal:  Drug Healthc Patient Saf       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.